Topical cyclosporine A in the management of dry eye disease in Sjögren's syndrome
- PMID: 39866306
- PMCID: PMC11758107
- DOI: 10.5114/reum/197334
Topical cyclosporine A in the management of dry eye disease in Sjögren's syndrome
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Topical cyclosporine a (0.05%) treatment in dry eye patients: a comparison study of Sjogren's syndrome versus non-Sjogren's syndrome.Int Ophthalmol. 2021 Apr;41(4):1479-1485. doi: 10.1007/s10792-021-01708-1. Epub 2021 Jan 23. Int Ophthalmol. 2021. PMID: 33484384
-
[A 0,05% cyclosporine treatment of the advanced dry eye syndrome].Klin Oczna. 2005;107(4-6):280-6. Klin Oczna. 2005. PMID: 16118939 Polish.
-
High-frequency topical cyclosporine 0.05% in the treatment of severe dry eye refractory to twice-daily regimen.Cornea. 2009 Dec;28(10):1091-6. doi: 10.1097/ICO.0b013e3181a16472. Cornea. 2009. PMID: 19770713 Free PMC article.
-
Dry eye in Sjögren's syndrome - characteristics and therapy.Eur J Ophthalmol. 2022 Nov;32(6):3174-3184. doi: 10.1177/11206721221091375. Epub 2022 Mar 30. Eur J Ophthalmol. 2022. PMID: 35354331 Review.
-
[Current treatments of xerophthalmia in Sjögren's syndrome].Rev Med Interne. 2004 May;25(5):376-82. doi: 10.1016/j.revmed.2003.10.009. Rev Med Interne. 2004. PMID: 15110955 Review. French.
References
Publication types
LinkOut - more resources
Full Text Sources